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ABSTRACT
The α-chemokine stromal-derived factor 1 (SDF-1), which binds to the CXCR4 
receptor, directs migration and homing of CXCR4+ hematopoietic stem/progenitor 
cells (HSPCs) to bone marrow (BM) stem cell niches. Nevertheless, it is also known 
that CXCR4−/− fetal liver-derived hematopoietic stem cells engraft into BM and that 
blockade of CXCR4 by its antagonist AMD3100 does not prevent engraftment of HSPCs. 
Because of this finding of SDF-1-CXCR4-independent BM homing, the unique role 
of SDF-1 in HSPC homing has recently been challenged. While SDF-1 is the only 
chemokine that chemoattracts HSPCs, other chemoattractants for these cells have 
recently been described, including the bioactive phosphosphingolipid sphingosine-1-
phosphate (S1P). To address the potential role of S1P in homing of HSPCs to BM, we 
performed hematopoietic transplants into mice deficient in BM-expressed sphingosine 
kinase 1 (Sphk1−/−) using hematopoietic cells from normal control mice as well as 
cells from mice in which floxed CXCR4 (CXCR4fl/fl) was conditionally deleted. We 
observed the presence of a homing and engraftment defect in HSPCs of Sphk1−/− mice 
that was particularly profound after transplantation of CXCR4−/− BM cells. Thus, our 
results indicate that BM-microenvironment-expressed S1P plays a role in homing of 
HSPCs. They also support the concept that, in addition to the SDF-1-CXCR4 axis, other 
chemotactic axes are also involved in homing and engraftment of HSPCs.
INTRODUCTION
Stromal-derived factor 1 (SDF-1), which binds 
to the seven-transmembrane-spanning G
αI
 protein-
coupled receptor CXCR4, is unique among the family 
of chemokines, because it chemoattracts hematopoietic 
stem/progenitor cells (HSPCs) [1–3]. Since the CXCR4 
receptor is expressed on HSPCs, SDF-1 plays an 
important role in regulating the trafficking of these cells 
and facilitates their homing and engraftment in BM 
after transplantation. Furthermore, SDF-1 is involved 
in the subsequent retention of HSPCs in BM stem cell 
niches [3–6].
Nevertheless, the role of the SDF-1-CXCR4 axis 
in stem cell homing to BM has been recently challenged 
by several observations that support the involvement of 
SDF-1-CXCR4-independent homing mechanisms [7–9]. 
This evidence is based on observations that i) CXCR4−/− 
fetal liver HSPCs home to BM in an SDF-1-independent 
manner [7], ii) homing of murine HSPCs made refractory 
to SDF-1 by incubation and co-injection with a CXCR4 
receptor antagonist (AMD3100) is normal or only mildly 
reduced [8], and iii) HSPCs in which CXCR4 has been 
knocked down by means of an SDF-1 intrakine strategy 
are still able to engraft [9]. It is also known that iv) 
myeloablative conditioning for transplantation induces 
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a highly proteolytic microenvironment in BM that leads 
to proteolytic degradation of SDF-1 and thus severely 
attenuates its chemotactic homing gradient [10].
Evidence has accumulated that one of the most 
potent chemotactic factors for HSPCs is the bioactive 
phosphosphingolipid sphingosine-1-phosphate (S1P) 
[11]. An S1P gradient in PB also plays a crucial role in 
mobilization of HSPCs from BM into PB [11–16]. The 
level of S1P in BM is regulated by a balance in activity 
between type 1 SP-1 kinase (Sphk1) and S1P lyase, which 
degrades S1P. Interestingly, in the past we observed that 
mice in which S1P lyase is inhibited by deoxypyridoxin 
(DOP) display an impaired release of HSPCs from BM 
to PB in response to mobilizing agents [11, 16]. This 
suggested the involvement of S1P in retention of HSPCs in 
BM. Based on this finding, we hypothesized that S1P plays 
a role also in homing and engraftment of HSPCs to BM 
and is involved in SDF-1-independent homing [10–12] 
what has been subsequently supported by observation that 
Sphk1-KO mice engraft poorly with WT BM cells exposed 
to AMD3100 [16]. To address this issue more directly and 
to shed more light on the role of BM-expressed S1P in 
the homing process, we performed homing experiments 
in Sphk1-deficient mice, transplanting these animals with 
wild type (WT) or CXCR4−/− HSPCs [17].
We report here a defect in homing as well as 
engraftment of WT and, in particular, CXCR4−/−HSPCs 
in Sphk1−/− mice. Thus, our data indicate that BM-
microenvironment-expressed S1P plays a role in the 
homing of HSPCs and supports the concept that other 
chemotactic axes in addition to the SDF-1-CXCR4 axis 
are involved in homing and engraftment of HSPCs.
RESULTS
Normal steady-state hematopoiesis in Sphk1−/− mice
Since Sphk1 is the main BM-expressed isoform of 
Sphk, we became interested in the basic hematopoietic 
parameters of animals that lack expression of this enzyme. 
Figure 1A, 1B shows that Sphk1−/− animals, in comparison 
with WT controls, display normal peripheral blood counts 
in all three major hematopoietic lineages. Moreover, these 
animals also have normal numbers of Sca-1+c-kit+Lin− 
(SKL) cells enriched for HSPCs in BM (Figure 1C). 
Furthermore, by employing in vitro clonogenic assays, 
we found that BM cells isolated from Sphk1−/− mice grow 
similar numbers of CFU-GM, BFU-E, and CFU-Meg 
colonies as normal control mice (Figure 1D).
Defective homing of WT BM cells in Sphk1−/− mice
Homing or lodging of HSPCs to BM after transplan-
tation precedes their engraftment and expansion in 
the hematopoietic microenvironment [3–6]. To study 
the homing process of HSPCs in Sphk1−/− animals, we 
transplanted BM cells isolated from green fluorescent 
protein (GFP) mice into lethally irradiated normal 
control or Sphk1−/− animals. Twenty-four hours after 
transplantation, the mice were sacrificed, and we evaluated 
the number of GFP+ cells in BM by FACS (Figure 2A) 
and the number of clonogenic progenitors that lodged 
during this time to BM, and we were able to grow in vitro 
GFP+ colonies after isolation from the long bones (Figure 
2B). We found that Sphk1−/− mice had significantly lower 
numbers of GFP+ cells and GFP+ clonogeneic progenitors 
in BM compared with normal control animals.
A defect in short-and long-term BM engraftment 
of HSPCs in Sphk1−/− animals
The outcome of a hematopoietic transplant is a 
function of homing/lodging efficiency and the number of 
transplanted cells. To study the role of BM-expressed S1P 
in the homing of HSPCs, we transplanted into Sphk1−/−mice 
normal control BM cells as well as CXCR4fl/fl BM cells in 
which expression of CXCR4 had been efficiently deleted 
by Cre-recombinase [17]. Our preliminary results indicated 
that the chemotactic responsiveness of normal control and 
CXCR4−/− BM clonogenic progenitors to S1P gradients was 
similar (Supplementary Figure S1).
Thus, we transplanted normal BM cells into normal 
(control) mice or Sphk1−/− animals and evaluated the 
number of day-11 CFU-GM colonies present in BM as 
well as the number of day-11 spleen colonies formed 
by CFU-S (Figure 3A) and found impaired homing of 
HSPCs to BM in Sphk1−/− mice. Similar and even more 
profound defects in the number of day-11 CFU-GM 
colonies and day-11 CFU-S colonies were observed after 
transplantation of CXCR4−/− BM cells (Figure 3B).
Based on these results, we transplanted normal BM 
cells or CXCR4−/− BM cells into lethally irradiated normal 
or Sphk1−/− mice and followed the recovery of white 
blood cells and platelet counts in these animals (Figure 
4A, 4B). We found that Sphk1−/−animals, compared with 
WT mice, showed a defect in recovery of leucocytes and 
platelets and that this defect was more pronounced if mice 
were transplanted with CXCR4−/− BM cells. As shown in 
Figure 4, the recovery of peripheral blood counts in Sphk1−/− 
mice after transplantation of CXCR4−/− cells was delayed by 
two weeks compared with normal mouse recipients.
DISCUSSION
The salient observation of this study is that BM-
expressed S1P is involved in homing and engraftment of 
HSPCs to BM. Despite the fact that the SDF-1-CXCR4 
axis is crucial for retention of HSPCs in BM niches and 
that Sphk1−/− mice do not show any hematopoietic defects 
under steady-state conditions, our results support the 
involvement of S1P in this process and the existence of 
an SDF-1-independent, S1P-mediated homing mechanism.
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Figure 1: Sphk1 deficiency does not affect hematological homeostasis. Bone marrows of WT and Sphk1−/− mice were isolated 
and evaluated for peripheral blood white blood cell A. and red blood cell B. parameters as well as the number of SKL cells in BM C. and 
in vitro clonogenic progenitor cells D. The data represent an average of at least six mice per experimental group.
Figure 2: A defect in homing of HSPCs from GFP+ mice in Sphk1−/− BM. Panel A. Lethally irradiated Sphk1−/− mice (six 
mice per group) were transplanted with 5 × 106 GFP+ bone marrow mononuclear cells (BMMNCs); 24 hours after transplantation femoral 
BMMNCs were harvested; the number of GFP+ cells in murine BM was evaluated by FACS (panel A); and the number of clonogenic 
GFP+ CFU-GM progenitors was enumerated in an in vitro colony assay (panel B). No colonies were formed in lethally irradiated and non-
transplanted mice (irradiation control). The data in panels A and B represent the combined results from two independent experiments (n = 
10). *p < 0.005.
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Overall, the developmental and postnatal migration 
of HSPCs is still not well understood. HSPCs migrate 
during embryonal development, colonizing different 
organs where hematopoiesis is initiated. In the second 
trimester of gestation, they colonize fetal liver, which is 
a major hematopoietic organ at this stage of development 
[18–20]. Despite the fact that SDF-1 is considered to be 
the most important factor regulating migration of HSPCs, 
surprisingly, murine embryos with CXCR4 or SDF-1 
knocked out have a normal number of myeloid HSPCs 
in fetal liver [21–24]. Because fetal liver is colonized 
by HSPCs migrating from the aorta-gonad-mesonephros 
(AGM) region, this result suggests that this process is 
mediated by chemoattractants other than SDF-1 [21–24]. 
Moreover, as mentioned in the introduction, HSPCs 
isolated from CXCR4−/− murine fetal liver home to BM 
in an SDF-1-independent manner [7], and it is also well 
known that homing of murine HSPCs made refractory 
to SDF-1 by incubation and co-injection with a CXCR4 
receptor antagonist (AMD3100) is normal or only mildly 
reduced [8]. Finally, as we demonstrate here, CXCR4−/− 
BM cells generated by a Cre-recombinase strategy also 
home to BM after transplantation, although the timing of 
the homing and engraftment process is delayed.
All this supports the conclusion that, in addition 
to the SDF-1-CXCR4 axis, additional redundant mecha-
nisms exist. Taking all this into consideration, we 
focused our investigation on the potential role of S1P. 
Figure 3: A defect in short-term engraftment of WT and CXCR4−/− HSPCs in Sphk1−/− BM. Panel A. Lethally irradiated 
mice (six mice per group) were transplanted with 1.5 × 105 bone marrow mononuclear cells (BMMNCs) from WT mice, and 11 days after 
transplantation spleens were removed and femoral BMMNCs were harvested for counting the number of CFU-S colonies and plating to 
count the number of CFU-GM colonies, respectively. Panel B. In similar experiments, mice were lethally irradiated and transplanted with 
1.5 × 105 BMMNCs from CXCR4−/− mice. Eleven days after transplantation, spleens were removed and femoral BMMNCs were harvested 
for counting the number of CFU-S colonies and plating to count the number of CFU-GM colonies, respectively. The data in panels A and 
B represent the combined results from three independent experiments (n = 9). *p < 0.005.
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Figure 4: A defect in long-term engraftment of WT and CXCR4−/− HSPCs in Sphk1−/− BM. Lethally irradiated Sphk1−/− mice 
were transplanted with 1 × 106 BMMNCs from WT or CXCR4−/− cells. White blood cells (panel A) and platelets (panel B) were counted 
at intervals (at 0, 5, 7, 11, 16, and 21 days and, for CXCR4−/− transplant, additionally at 28, 35, 42, and 49 days after transplantation). For 
platelets count changes have been shown in % in comparison to day 0 for which platelet counts were assumed to be 100%. Results are 




This phosphosphingolipid is a potent chemoattractant 
for HSPCs, even more potent than SDF-1 if employed 
at the physiological doses that are encountered in 
biological fluids [11]. Because of its chemical structure, 
S1P, in contrast to peptide-based SDF-1, is resistant, to 
destruction by proteolytic enzymes, which are highly 
upregulated in the BM microenvironment when it is 
irradiated or conditioned by chemotherapy [10]. S1P 
has been demonstrated to be involved in trafficking of 
HSPCs, and, as recently demonstrated by us and others, 
S1P present in PB is involved in egress of HSPCs from 
BM during the mobilization process [11–16].
Interestingly, our previous research demonstrated 
that mobilization of HSPCs is impaired in mice after 
inhibition of S1P lyase, which degrades S1P and thus 
increases its level in BM [25]. This observation, along 
with the fact that S1P is upregulated after conditioning 
for transplantation in the BM microenvironment [11], 
prompted us to study its role in the homing process.
We report here that Sphk1−/− mice, deficient in S1P 
level in BM, display impaired homing of transplanted 
HSPCs. Since these mice have a normal level of 
SDF-1 in BM, the lack of S1P in the hematopoietic 
microenvironment was compensated after transplantation 
of normal control BM cells by chemoattraction through 
the SDF-1-CXCR4 axis. However, if we performed 
transplants into Sphk1−/− mice employing CXCR4−/− BM 
cells, we observed delayed long-term engraftment of 
the transplanted cells, and this experiment revealed the 
importance of the S1P homing mechanism.
However, the fact that CXCR4−/− cells were finally 
able to engraft in Sphk1−/− mice suggests the existence 
of other chemoattractants that are involved in this 
process in addition to SDF-1 and S1P. In support of this 
inference, it has been demonstrated that another bioactive 
phosposphingolipid, ceramide-1-phosphate (C1P), is 
also a potent chemoattractant for HSPCs [10]. We have 
reported that, like the S1P level, the C1P level is also 
increased in BM after myeloablative conditioning for 
transplantation [10, 11]. The problem with studying the 
possible involvement of C1P in the homing process is that 
the receptor/s for C1P has not yet been identified, and thus 
the appropriate murine knockout experimental models are 
not available.
Other potential factors involved in the homing 
process are extracellular nucleotides such as ATP or UTP 
[26–28]. We have recently reported that the concentration 
of extracellular nucleotides also increases in BM after 
irradiation [29, 30]. Thus, it would be interesting to see 
the effect of extracellular nucleotide receptor blockage on 
homing and engraftment of HSPCs, and we are currently 
planning such experiments.
Despite the fact that some crucial chemotactic 
factors for HSPCs, including SDF-1, S1P, C1P, and 
extracellular nucleotides (e.g., ATP and UTP), have 
been identified, we cannot exclude the possibility that 
there are other molecules and mechanisms involved in 
homing that could compensate for an SDF-1-CXCR4 
axis deficiency. For example, the involvement of Ca2+-
sensing mechanisms in the migration of HSPCs has been 
described [31]. A similar H+-sensing mechanism could 
also be involved, but this requires further study.
It is well known that SDF-1 can also bind to the 
CXCR7 receptor, but the involvement of the SDF-
1-CXCR7 axis in the homing of HSPCs is based on 
inconclusive evidence. Nevertheless, it would be 
interesting to perform homing experiments in Sphk1−/− 
animals with HSPCs in which both CXCR4 and 
CXCR7 receptors are eliminated from the cell surface. 
An alternative strategy would be to perform transplant 
experiments into Sphk1−/− mice in which stromal SDF-1 
is conditionally knocked out.
An important question is how conditional CXCR4 
knockout BM cells engrafted in our mouse models 
could be theoretically explained by an SDF-1 priming 
phenomenon [32]. It is known that several soluble 
factors released during conditioning for transplantation, 
including elements of innate immunity, such as cleavage 
fragments of C3 [33]; cationic antimicrobial peptides, such 
as cathelicidin (LL-37) [34] and β2-defensin [35]; and 
prostaglandin E2 (PGE2) [36], a member of the eicosanoid 
family, significantly enhance responsiveness of the SDF-
1-CXCR4 axis. However, since CXCR4 was deleted by 
~99% by Cre-recombinase in the HSPCs employed in our 
experiments, SDF-1 priming effects are most likely not 
involved.
In these experiments we did not address which of the 
S1P receptors is most crucial for the observed phenomena, 
but, based on the responsiveness of HSPCs to an S1P 
gradient, the most likely candidate in S1P-mediated 
homing is the S1P type 1 receptor (S1P1R) [11–16].
In conclusion, we demonstrated a defect in homing as 
well as engraftment of WT HSPCs and, most importantly, 
CXCR4−/− HSPCs in Sphk1−/− mice. Thus, our results 
indicate that S1P expressed in the BM-microenvironment 
plays a role in homing of HSPCs and supports the concept 
that other chemotactic axes are involved in homing and 
engraftment of HSPCs in addition to the SDF-1-CXCR4 
axis (Figure 5). Further studies are needed to evaluate the 
involvement of other potential homing factors, such as 
C1P, extracellular nucleotides (e.g., ATP), Ca2+ sensing 
mechanism, PGE2 involvement and a role of hyaluronic 
acid - CD44 interaction [11, 12, 27, 31, 36, 39–42], that 
may compensate for SDF-1-and S1P-mediated homing.
MATERIAL AND METHODS
Animals
Sphk1−/− 6–8-week-old mice and age-and sex-matched 
littermates, all employed in homing experiments, as well as 
green immunofluorescence protein (GFP)-expressing mice 
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were purchased from The Jackson Laboratory, Bar Harbor, 
ME. Cxcr4fl/fl mice (provided by Dr. Yong-Rui Zou, The 
Feinstein Institute for Medical Research) were crossed 
with B6.Cg-Tg(UBC-cre/ERT2)1Ejb/J mice (Jackson 
Labolatory) to generate CXCR4fl/flCreTg/− mice [17]. To delete 
Cxcr4, mice were injected intraperitoneally with tamoxifen 
(80 mg/kg/day, Sigma-Aldrich) for five consecutive days. 
The efficiency of recombination was evaluated in peripheral 
blood and bone marrow after the last tamoxifen injection 
and was greater than 99%. Animal studies were approved 
by the Animal Care and Use Committee of the University of 
Louisville (Louisville, KY).
Peripheral blood (PB) parameter counts
To obtain leukocyte and red blood cells counts, 
50 microliters of PB were taken from the retro-orbital 
plexus of the mice into EDTA-coated Microvette tubes 
(Sarstedt Inc., Newton, NC, USA) and run within 
2 h of collection on a HemaVet 950FS hematology 
analyzer (Drew Scientific Inc., Oxford, CT, USA) as 
described [11].
FACS analysis
The following monoclonal antibodies were 
employed to perform analytical staining of Lin−/Sca-
1+/c-kit+ (SKL cells) and Lin−/Sca-1+/CD45+ (HSCs): 
fluorescein isothiocyanate (FITC) anti-CD117 (c-kit) 
(clone2B8; BioLegend, San Diego, CA) and phycoerythrin 
(PE)-Cy5 anti-mouse Ly-6A/E (Sca-1) (clone D7; 
eBioscience™, San Diego, CA). All anti-mouse lineage 
markers (Lin) were conjugated with PE and purchased 
from BD Biosciences: anti-CD45R/B220 (clone RA3-
6B2); anti-Ter-119 (clone TER-119); anti-CD11b (clone 
M1/70); anti-T-cell receptor β (TCRβ; clone H57-597); 
Figure 5: The proposed major mechanism underlying the processes of homing of HSPCs. HSPCs infused into blood respond 
to a gradient of SDF-1 between bone marrow and blood; however, conditioning for transplantation by chemoradiotherapy may also upregulate 
other homing factors, such as S1P and C1P, and increase the levels of extracellular nucleotides (ATP and UTP). Homing is also regulated by 
Ca2+ gradient in the BM microenvironment. Most likely, there are also other unidentified yet factors involved in the homing process.
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anti-Gr-1 (clone RB6-8C5); anti-TCRγδ (clone GL3); 
and anti-CD45 (clone 30-F11). All monoclonal antibodies 
were added at saturating concentrations, and the cells 
were then incubated for 30 min on ice, washed twice, 
resuspended in RPMI-1640 plus 2% fetal bovine serum, 
and analyzed with an LSR II flow cytometer (BD, San 
Diego, CA, USA) [11].
Clonogenic in vitro assay
After red blood cells (RBCs) from PB were lysed 
(Pharm Lyse buffer, BD Biosciences, San Jose, CA), 
the nucleated cells were subsequently washed twice 
and used for CFU-GM colony formation, and cells were 
counted and resuspended in human methylcellulose 
base media provided by the manufacturer (R&D 
Systems, Inc., Minneapolis, MN), supplemented with 
25 ng/ml recombinant murine granulocyte macrophage 
colony-stimulating factor (mGM-CSF) and 10 ng/ml 
recombinant murine interleukin 3 (mIL-3; Millipore, 
Billerica, MA). Cultures were incubated for 7 days 
and then scored for the number of CFU-GM colonies 
under an inverted microscope. We cultured 1 × 106 
peripheral blood mononuclear cells (PBMNCs)/
dish, and final results were recalculated based on the 
number of PBMNCs per 1 μl of PB. Each clonogenic 
test was performed in duplicate. To evaluate the 
number of clonogenic progenitor cells, bone marrow 
mononuclear cells (BMMNCs) were supplemented 
with erythropoietin (EPO, 5 unit/ml, Stem Cell Tech) 
plus stem cell factor (SCF, 5 ng/ml), resuspended in 
methylcellulose base medium for burst-forming units 
(BFU-E), supplemented with thrombopoietin (TPO, 
100 ng/ml) plus interleukin-3 (mIL-3, 10 ng/ml), and 
resuspended in plasma cloth cultures for determining the 
number of CFU-megakaryocytes (Megs) and CFU-GM 
colonies, performed as above. Cultures were incubated 
for 7 days (37°C, 95% humidity, and 5% CO2), at which 
time they were scored under an inverted microscope for 
the number of colonies, as described [11].
Short-term homing experiments
Mice were irradiated with a lethal dose of 
γ-irradiation (1000 cGy). After 24 h, the animals were 
transplanted (by tail vein injection) with 5 × 106 BM cells 
from GFP mice. At 24 h after transplant, BM cells from the 
femurs were isolated via Ficoll-Paque and divided. Some 
cells (5 × 105) were incubated with Vybrant® DyeCycle™ 
Ruby stain (Invitrogen, CA) and analyzed on a flow 
cytometer. The rest of the cells were plated in serum-free 
methylcellulose cultures and stimulated to grow CFU-GM 
colonies with granulocyte macrophage-colony stimulating 
factor (GM-CSF, 25 ng/ml) and interleukin 3 (IL-3, 10 
ng/ml). After 7 days of incubation (37°C, 95% humidity, 
and 5% CO2) the number of colonies was scored under an 
inverted microscope [37].
Evaluation of engraftment
For engraftment experiments, mice were irradiated 
with a lethal dose of γ-irradiation (1000 cGy). After 24 
h, mice were transplanted with 1.5 × 105 BM cells from 
WT or Cxcr4−/− mice by tail vein injection. Femora of 
transplanted mice were flushed with phosphate-buffered 
saline (PBS) on day 12 post-transplant. Purified via Ficoll-
Paque, BM cells were plated in serum-free methylcellulose 
cultures and stimulated to grow CFU-GM colonies with 
G-CSF (25 ng/ml) plus IL-3 (10 ng/ml). After 7 days of 
incubation (37°C, 95% humidity, and 5% CO2) the number 
of colonies was scored under an inverted microscope. 
Spleens were also removed, fixed in Telesyniczky’s 
solution for CFU-S assays, and colonies were counted on 
the surface of the spleen [38].
Recovery of leukocytes and platelets
For transplantation experiments, mice were 
irradiated with a lethal dose of γ-irradiation (1000 cGy). 
After 24 h, the mice were transplanted by tail vein 
injection with 1 × 106 BM cells. Transplanted mice were 
bled at various intervals from the retro-orbital plexus to 
obtain samples for white blood cell and platelet counts as 
described [37].
Chemotaxis assay
BMMNCs from WT and Cxcr4−/− mice at a density 
of 1 × 106 in 100 μl were aliqoted into 5-μm polycarbonate 
membrane inserts in a Costar Transwell 24-well plate (Costar 
Corning, Cambridge, MA, USA) for 3 h chemotaxis at 
37°C. Medium with 0.5% BSA (650 μl/well) containing 
either no chemoattractant (negative control) or sphingosine-
1-phosphate (0.1 μM, Cayman Chemical, Michigan, USA) 
was added to the lower chambers of the plate. Subsequently, 
cells in the lower chambers were harvested and assayed 
for the number of CFU-GM colony-forming units. Briefly, 
cells were resuspended in human methylcellulose base 
medium provided by the manufacturer (R&D Systems), 
supplemented with GM-CSF (25 ng/ml) and IL-3 (10 ng/ml) 
for determining the number of CFU-GM colonies. Cultures 
were incubated for 7 days, at which time they were scored 
under an inverted microscope for the number of colonies [11].
Statistical analysis
All results are presented as mean ± SD. Statistical 
analysis of the data was done using Student’s t-test for 
unpaired samples, with p ≤ 0.05 considered significant.
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